Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Current developments in the use of biomarkers for juvenile idiopathic arthritis.

Current rheumatology reports - 1 Mar 2014

Duurland Chantal L, Wedderburn Lucy R

Abstract excerpt

Use of biomarkers in clinical practice has proved extremely valuable and is a rapidly expanding field. However, despite the huge potential of biomarkers, for juvenile idiopathic arthritis (JIA) there are currently no validated paediatric biomarkers available to help with setting up a more tailored approach on which drug choice could be based, to achieve remission early in the course of disease. Early remission...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antirheumatic Agents
Share to Arthritis, Juvenile
Share to Biomarkers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Phenotype

Share to Prognosis

Share to Remission Induction

Source

Open in PubMed Open full text

Identifiers

PMID: 24445961
DOI: 10.1007/s11926-013-0406-3
PMCID: PMC3930839

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Current developments in the use of biomarkers for juvenile idiopathic arthritis.PMID 24445961Read ↗

Advancements and progress in juvenile idiopathic arthritis: A Review of pathophysiology and treatment.Semantic proximity Read ↗

Diagnosis and classification of juvenile idiopathic arthritis.Semantic proximity Read ↗

In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?Semantic proximity Read ↗

Biomarkers in Systemic Juvenile Idiopathic Arthritis, Macrophage Activation Syndrome and Their Importance in COVID EraSemantic proximity Read ↗

Biomarkers Associated with Organ-Specific Involvement in Juvenile Systemic Lupus Erythematosus.Semantic proximity Read ↗

New advances in juvenile idiopathic arthritis.Semantic proximity Read ↗

Biomarkers in Childhood-Onset Systemic Lupus Erythematosus.Semantic proximity Read ↗

Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.Semantic proximity Read ↗

Polyarticular juvenile idiopathic arthritis – epidemiology and management approachesSemantic proximity Read ↗

The genetics of juvenile idiopathic arthritis: current understanding and future prospects.Semantic proximity Read ↗

The epigenetic determinants for systemic juvenile idiopathic arthritis phenotyping and treatment response.Semantic proximity Read ↗

Current Medical Treatments for Juvenile Idiopathic ArthritisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.